AstraZeneca in deal with China firm worth up to £4bn
Astra has agreed a deal that could be worth almost £4billion with a Chinese company to use AI in the production of new treatments for chronic diseases.
You are not logged in so some information on this page has been withheld. To see more, please log in.
Astra
since
auto-detected in 9 stories
3 days ago
page 1 of 1